. . . . . . . . . . . . "[In sharp contrast to etanercept, infliximab strongly suppresses genes associated with Type 1 immune responses (IFN-gamma and the IL-12-receptor beta 2 subunit), providing a clear mechanism for clinically relevant immune suppression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2016-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2016-05-13T12:46:22+02:00"^^ . . . . . . . . . . . "v4.0.0.0" . "v4.0.0" .